Molnupiravir covid medicine: Amid the resurgence of COVID-19 cases across the country, the selection expert committee of the Central Drugs Standard Control Organization has approved an anti-viral drug Molnupiravir for use in emergency situations. The well-known life saving drug Molnupiravir was earlier approved by the US Drug Controller FDA and UK’s MHRA for the treatment of COVID-19 in adults and now the approval of this drug in India is a step towards COVID management. Considered a big step.
After getting the approval of this drug, Mankind Pharma, one of the largest pharma companies of the country, has started manufacturing Molnupirvir on a large scale. The company claims that the drug, which will soon be available in the market, will cost Rs 35 per capsule and the entire course will cost Rs 1400, which will be the most economical in the market. According to another claim of the company, the shelf life of this medicine is also 18 months, which is better than this medicine of other companies. It is important to note that although this medicine is a prescribed drug and cannot be taken without a doctor’s advice and prescription, nor is it allowed to be given to pregnant women and people below the age of 18 years.
How Molnupiravir works
According to doctors, this antiviral tablet is helpful in reducing the load of corona virus in people with mild infection of Kovid. It reduces the symptoms of the disease in the patient’s body by reducing the virus load in the body. Doctors believe that this can be helpful in reducing the burden of patients on hospitals and in preventing the increasing Kovid infection in poor countries. This pill is also expected to strengthen the fight against the epidemic.
Disclaimer: ABP News does not endorse the methods, methods and claims mentioned in this article. Take these only as suggestions. Consult a doctor before following any such treatment/medication/diet.
See below health equipment-
Calculate your body mass index (BMI)